Having challenged the idea that our environment cannot alter our genetically controlled 24-hour sleep-wake cycle, circadian rhythm researcher Jennifer Hurley has embarked on a new project tracing the mechanism between environmental signals and the circadian clock.

Faculty from Rensselaer Polytechnic Institute served as experts in an exchange of information about developments in the field of sustainable energy, large-scale environmental change, and innovative and interdisciplinary research into energy storage and smart systems in the built environment on a recent visit by two members of the U.S. Congress.

A team including Rensselaer Polytechnic Institute researcher Gaetano Montelione has identified the design principles for creating large “ideal” proteins from scratch, paving the way for the design of proteins with new biochemical functions. The results were published today in Nature Communications.

The Jefferson Project at Lake George — a groundbreaking collaboration between IBM Research, Rensselaer Polytechnic Institute, and The FUND for Lake George — is expanding its statewide leadership role in the study of harmful algal blooms and other water-quality threats this summer with a new $1 million research project on Chautauqua Lake in Chautauqua County, made possible through funding from Chautauqua Institution and a county coalition. 

The U.S. Food and Drug Administration has approved a new drug for treating schizophrenia and bipolar I disorder that includes samidorphan, a new chemical entity discovered at Rensselaer Polytechnic Institute.

Oxygen levels in the world’s temperate freshwater lakes are declining rapidly — faster than in the oceans — a trend driven largely by climate change that threatens freshwater biodiversity and drinking water quality.

As more dissolved organic matter enters lakes across the northeast United States, darkening the lakes in a phenomena called “browning,” new research shows that these waters may be growing less productive and able to sustain less life.

When combined with drugs currently used to treat hepatitis C, the antiviral remdesivir is 10 times more effective in treating cells infected with SARS-CoV-2, the virus that causes COVID-19.

With a prestigious National Science Foundation Faculty Early Career Development (CAREER) grant, researcher Kevin Rose will examine large-scale patterns in concentrations of carbon dioxide (CO2) and dissolved oxygen .

Using a nanopore, researchers have demonstrated the potential to reduce the time required for sequencing a glycosaminoglycan — a class of long chain-linked sugar molecules as important to our biology as DNA — from years to minutes.